Cargando…
Isocitrate dehydrogenase 1 mutation drives leukemogenesis by PDGFRA activation due to insulator disruption in acute myeloid leukemia (AML)
Acute myeloid leukemia (AML) is characterized by complex molecular alterations and driver mutations. Elderly patients show increased frequencies of IDH mutations with high chemoresistance and relapse rates despite recent therapeutic advances. Besides being associated with global promoter hypermethyl...
Autores principales: | Steinhäuser, Sophie, Silva, Patricia, Lenk, Lennart, Beder, Thomas, Hartmann, Alina, Hänzelmann, Sonja, Fransecky, Lars, Neumann, Martin, Bastian, Lorenz, Lipinski, Simone, Richter, Kathrin, Bultmann, Miriam, Hübner, Emely, Xia, Shuli, Röllig, Christoph, Vogiatzi, Fotini, Schewe, Denis Martin, Yumiceba, Veronica, Schultz, Kristin, Spielmann, Malte, Baldus, Claudia Dorothea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883162/ https://www.ncbi.nlm.nih.gov/pubmed/36411356 http://dx.doi.org/10.1038/s41375-022-01751-6 |
Ejemplares similares
-
Heterodimerization of AML1/ETO with CBFβ is required for leukemogenesis but not for myeloproliferation
por: Thiel, V N, et al.
Publicado: (2017) -
AP-1 Transcription Factor Complex Members FOSB and FOS are Linked With CNS Infiltration and Inferior Prognosis in Childhood T-ALL
por: Spory, Lea, et al.
Publicado: (2023) -
TAF1 plays a critical role in AML1-ETO driven leukemogenesis
por: Xu, Ye, et al.
Publicado: (2019) -
A cohesive look at leukemogenesis: The cohesin complex and other driving mutations in AML
por: Heimbruch, Katelyn E., et al.
Publicado: (2021) -
Targeting FGFR1 to suppress leukemogenesis in syndromic and de novo AML in murine models
por: Wu, Qing, et al.
Publicado: (2016)